Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice

Due to the severity of CMV infection in immunocompromised individuals the development of a vaccine has been declared a priority. However, despite the efforts made there is no yet a vaccine available for clinical use. We designed an approach to identify new CMV antigens able to inducing a broad immune response that could be used in future vaccine formulations. We have used serum samples from 28 kidney transplant recipients, with a previously acquired CMV-specific immune response to identify viral proteins that were recognized by the antibodies present in the patient serum samples by Western blot. A band of approximately 45 kDa, identified as UL44, was detected by most serum samples. UL44 immunogenicity was tested in BALB/c mice that received three doses of the UL44-pcDNA DNA vaccine. UL44 elicited both, a strong antibody response and CMV-specific cellular response. Using bioinformatic analysis we demonstrated that UL44 is a highly conserved protein and contains epitopes that are able to activate CD8 lymphocytes of the most common HLA alleles in the world population. We constructed a UL44 ORF deletion mutant virus that produced no viral progeny, suggesting that UL44 is an essential viral protein. In addition, other authors have demonstrated that UL44 is one of the most abundant viral proteins after infection and have suggested an essential role of UL44 in viral replication. Altogether, our data suggests that UL44 is a potent antigen, and favored by its abundance, it may be a good candidate to include in a vaccine formulation.

Bibliographic Details

Main Authors:	Mancebo, Francisco J., Nuévalos, Marcos, Lalchandani, Jaanam, Martín Galiano, Antonio J., Fernández-Ruiz, Mario, Aguado, José María, García-Ríos, Estéfani, Pérez Romero, Pilar
Other Authors:	Ministerio de Ciencia, Innovación y Universidades (España)
Format:	artículo biblioteca
Language:	English
Published:	Elsevier 2024-05-15
Subjects:	CMV-Specific immune response, Cytomegalovirus, Neutralizing antibodies, Vaccine, immune response, vaccines,
Online Access:	http://hdl.handle.net/10261/360524 https://api.elsevier.com/content/abstract/scopus_id/85193433205
Tags:	Add Tag No Tags, Be the first to tag this record!